Esopase Capsules 40 mg Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Esopase Capsules 40 mg.

Available Products of Esopase Capsules 40 mg

Esopase Capsules 40 mg 14's

Reg#: 048376

Description of Esopase Capsules 40 mg

Esomeprazole 40 mg

Medicine Info

Pack Size: 14's

Company: Lucky Core Industries Limited

Price of Esopase Capsules 40 mg

Price: Rs. 409.98

Related Keywords

  • Esopase Capsules 40 mg price in Pakistan
  • Esopase Capsules 40 mg tablet price
  • Esopase Capsules 40 mg Capsule price
  • Lucky Core Industries Limited Esopase Capsules 40 mg price
  • Buy Esopase Capsules 40 mg online
  • Esopase Capsules 40 mg uses
  • Esopase Capsules 40 mg syrup price
  • Esopase Capsules 40 mg pack 14's cost

Esopase Capsules 40 mg 24's

Reg#: 048376

Description of Esopase Capsules 40 mg

Each Capsule contains:Esomeprazole Magnesium trihydrate eq. to Esomeprazole….40mg

Medicine Info

Pack Size: 24's

Company: Lucky Core Industries Limited

Price of Esopase Capsules 40 mg

Price: Rs. 702.82

Related Keywords

  • Esopase Capsules 40 mg price in Pakistan
  • Esopase Capsules 40 mg tablet price
  • Esopase Capsules 40 mg Capsule price
  • Lucky Core Industries Limited Esopase Capsules 40 mg price
  • Buy Esopase Capsules 40 mg online
  • Esopase Capsules 40 mg esomeprazole40mg uses
  • Esopase Capsules 40 mg syrup price
  • Esopase Capsules 40 mg pack 24's cost

Alternatives brands of Esopase Capsules 40 mg

Explore alternative brands for Esopase Capsules 40 mg below.

View Alternatives

Explore More Medicines

Tenoret-50 Tablets

Lucky Core Industries Limited

MRP: Rs. 334.0920

Ceptin Suspension 125mg:5ml

Lucky Core Industries Limited

MRP: Rs. 206.0160

Ceptin Suspension250mg:5ml

Lucky Core Industries Limited

MRP: Rs. 351.6720

Xelna Tablets 180mg

Lucky Core Industries Limited

MRP: Rs. 534.6000

Xelna Talets. 120mg

Lucky Core Industries Limited

MRP: Rs. 356.3880

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!